'Multiple dose' presentation slideshows

Clinically Relevant Toxicology

Clinically Relevant Toxicology. Tina Wismer DVM, DABVT, DABT ASPCA Animal Poison Control Center Urbana, IL. Silica Gel Dessicants. Silica is considered chemically and biologically inert Mild GI signs possible. Ant and Roach Baits.

1.48k views • 91 slides

The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD

The General Concepts of Pharmacokinetics and Pharmacodynamics Hartmut Derendorf, PhD University of Florida. PHARMACOKINETICS what the body does to the drug PHARMACODYNAMICS what the drug does to the body. Pharmacokinetics conc. vs time. Pharmacodynamics conc. vs effect. 0.4. 1. Conc.

997 views • 50 slides

Prequalification programme: Priority essential medicines

451 views • 28 slides

Phenylpropanolamine

Phenylpropanolamine. R. William Soller, Ph.D. Senior Vice President and Director of Science & Technology Consumer Healthcare Products Association Washington, DC October 19, 2000. Outline. Background Independent Expert Panel Conclusion.

488 views • 25 slides

Clinical trials for regulatory approval of biosimilars

Shravanti Bhowmik M.D. Clinical Research Sun Pharma Advanced Research Company. Clinical trials for regulatory approval of biosimilars. Agenda. Clinical trials for regulatory approval of biosimilars (guidelines) Challenges in trial endpoints

351 views • 17 slides

Case studies

Case studies. Saila Antila, PhD WHO consultant Training workshop on Pharmaceutical Quality, Good Manufacturing Practice & Bioequivalence, Kiev 3.-7.10.2005. Case study 1. Characteristics of drug X half-life, conventional preparations: 4-6 h

367 views • 15 slides

Case studies

Case studies. Saila Antila, PhD WHO consultant Training workshop on Pharmaceutical Quality, Good Manufacturing Practice & Bioequivalence, Kiev 3.-7.10.2005. Case study 1. Characteristics of drug X half-life, conventional preparations: 4-6 h

397 views • 15 slides

Packaging of injections

Packaging of injections. Containers for injection ideal properties. Does not affect its contents No surface changes at temp. & pressure associated with sterilization Should protect from light when the contents are photosensitive

463 views • 15 slides

GS-9350: A Pharmacoenhancer Without anti-HIV Activity

GS-9350: A Pharmacoenhancer Without anti-HIV Activity. AA Mathias, P German, M Lee, C Callebaut, L Xu, L Tsai, B Murray, H Liu, K Yale, D Warren and BP Kearney Gilead Sciences Foster City, CA, USA. Potent, irreversible (mechanism-based) inhibition of CYP3A No anti-HIV activity.

266 views • 13 slides

preservatives

preservatives. PHT 434. prreservatives. Preservative: Is a substance or mixture of substances added to a product formulation to prevent the growth of, or to destroy of , microorganisms introduced accidently once the container is opened for use. Why using preservatives?.

881 views • 12 slides

preservatives

preservatives. PHT 434. prreservatives. Preservative: Is a substance or mixture of substances added to aproduct formulation to prevent the growth of, or to destroy, microorganisms introduced accidently once the container is opened for use. Why using preservatives?.

131 views • 12 slides

preservatives

preservatives. PHT 434. prreservatives. Preservative: Is a substance or mixture of substances added to aproduct formulation to prevent the growth of, or to destroy, microorganisms introduced accidently once the container is opened for use. Why using preservatives?.

194 views • 12 slides